Related Experiment Video

Updated: Aug 6, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis

Antonio Ruggiero1,2,3, Chiara Redemagni4,3, Cristina Angela Camnasio1,2

  • 1Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Journal of Medical Cases
|July 23, 2026
PubMed
Summary

Immune checkpoint inhibitors (ICIs) show potential safety in select advanced endometrial cancer patients with stable multiple sclerosis (MS). Careful patient selection and monitoring are key for managing MS during cancer treatment.

Keywords:
Disease modifying therapiesDostarlimabEndometrial cancerImmune checkpoint inhibitorsMultiple sclerosis

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.